Waldencast plc (WALD) News
Follow Waldencast plc (WALD) news in one place: company catalysts, earnings, analyst actions and wider market developments. Review 5 public stories across 3 publication days to understand how the story developed. Public news appears after a 15-minute delay; LiveCast subscribers can follow new headlines and hear important updates without this additional delay.
L
Waldencast plc (WALD) H1 Revenue Falls 57%; Plans Nasdaq Delisting
Waldencast plc reported H1 2026 Milk Makeup net revenue of $26.1M, down 57% YoY, and Adjusted EBITDA of -$14.8M. It completed the sale of Obagi Medical for up to $460M, repaid $178.4M debt, recorded a $52.3M goodwill imp
EARNINGS | Sep 28, 2026, 08:40 PM UTC
L
Waldencast plc Announces First Half 2026 Financial Results
NEW YORK, Sept. 28, 2026 (GLOBE NEWSWIRE) -- Waldencast plc NASDAQ:WALD (“Waldencast” or the “Company”), the parent company of Milk Makeup, the clean prestige beauty brand born from the creative community of Milk Studios
EARNINGS | Sep 28, 2026, 08:39 PM UTC
L
Waldencast (WALD) Files to Delist From Nasdaq, Deregister
Waldencast filed Form 25 to remove its Class A shares and warrants from Nasdaq, expecting last trading day on or about Oct 2, 2026, and plans to file Form 15 on or about Oct 5, 2026 to suspend SEC reporting. Section 12(b
REGULATION | Sep 24, 2026, 08:42 PM UTC
L
Waldencast plc Files Form 25 to Voluntary Delist from Nasdaq and Deregister its Securities under the Exchange Act
LONDON, Sept. 24, 2026 (GLOBE NEWSWIRE) -- Waldencast plc NASDAQ:WALD (“Waldencast” or the “Company”) today announced that it has filed a Form 25 (Notification of Removal from Listing) with the Securities and Exchange Co
REGULATION | Sep 24, 2026, 08:42 PM UTC
H
Waldencast Sells Obagi Medical
Waldencast completes Obagi Medical sale
MNA | Jul 30, 2026, 08:30 PM UTC